RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: ankylosing spondylitis
Accession: DOID:7147
browse the term
Definition: An arthritis that results_in inflammation in the joints of the spine and pelvis. The disease has_symptom pain, has_symptom stiffness in the spine, has_symptom stiffness in the neck, has_symptom stiffness in the hips, has_symptom stiffness in the jaw and has_symptom stiffness in the rib cage. (DO)
Synonyms: exact_synonym: Bechterew Disease; Bechterew syndrome; Bechterew's disease; Bechterews disease; Bekhterev syndrome; Bekhterev's disease; Marie Struempell disease; Marie Strumpell spondylitis; Marie-Strumpell disease; ankylosing spondylarthritides; ankylosing spondylarthritis; ankylosing spondyloarthritides; ankylosing spondyloarthritis; rheumatoid spondylitis; spondylarthritis ankylopoietica; spondylitis ankylopoietica; spondyloarthritis ankylopoietica
related_synonym: ankylosing spondylitis, susceptibility to
primary_id: MESH:D013167
xref: EFO:0003898 ; GARD:9518 ; ICD10CM:M45 ; ICD9CM:720.0 ; MIM:PS106300 ; NCI:C84564 ; ORDO:825
For additional species annotation, visit the
Alliance of Genome Resources .
G
ACE
angiotensin I converting enzyme
susceptibility
IAGP
DNA:deletion:intron:IVS16+1464-1751del (human)
RGD
PMID:22876137
RGD:7829800
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
IEP
protein:increased expression:serum
RGD
PMID:21122270
RGD:5686891
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ANO6
anoctamin 6
severity
IAGP EXP
DNA:SNP: :rs17095830(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22138694 PMID:23308121
RGD:9684849
NCBI chr12:45,216,095...45,440,404
Ensembl chr12:45,215,987...45,482,280
G
ANTXR2
ANTXR cell adhesion molecule 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20062062 PMID:21743469
NCBI chr 4:79,901,146...80,073,472
Ensembl chr 4:79,901,146...80,125,454
G
ASPN
asporin
susceptibility
IAGP
DNA:repeats:exon:
RGD
PMID:20144272
RGD:9684964
NCBI chr 9:92,456,205...92,482,506
Ensembl chr 9:92,456,205...92,482,506
G
CARD9
caspase recruitment domain family member 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr 9:136,363,956...136,373,669
Ensembl chr 9:136,363,956...136,373,681
G
CRP
C-reactive protein
disease_progression
IEP
protein:increased expression:serum:
RGD
PMID:22422197 PMID:6605119
RGD:6482308 , RGD:9491788
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
IAGP
DNA:polymorphism: :4887C>A (human)
RGD
PMID:12880680
RGD:1581252
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
ERAP1
endoplasmic reticulum aminopeptidase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17952073 PMID:20062062 PMID:21743469 PMID:23291587
NCBI chr 5:96,760,813...96,935,854
Ensembl chr 5:96,760,810...96,808,100
G
ERAP2
endoplasmic reticulum aminopeptidase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33550689
NCBI chr 5:96,875,939...96,919,716
Ensembl chr 5:96,875,986...96,919,703
G
FCGR3A
Fc gamma receptor IIIa
severity
IEP
protein:decreased expression:polymorphonuclear leucocyte
RGD
PMID:8453794
RGD:5508388
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
HLA-B
major histocompatibility complex, class I, B
susceptibility no_association
IAGP EXP
DNA:polymorphisms:cds:HLA-B27, HLA-B60 (human, Caucasian) DNA:polymorphism:cds:HLA-B2705 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8053961 PMID:21743469 PMID:22138694 PMID:8733445 PMID:21927904
RGD:7364914 , RGD:10755579
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
severity
IAGP
DNA:polymorphism:cds:HLA-DQA1*0401 (human)
RGD
PMID:19565552
RGD:5147611
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
severity
IAGP
DNA:polymorphism:cds:HLA-DQB1*0603 (human)
RGD
PMID:19565552
RGD:5147611
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
severity
IAGP
DNA:polymorphisms:cds:HLA-DRB1*0801, HLA-DRB1*0804 (human)
RGD
PMID:19565552
RGD:5147611
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
IGFBP3
insulin like growth factor binding protein 3
IEP
protein:decreased expression:serum
RGD
PMID:9851264
RGD:10402573
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
IL12B
interleukin 12B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
IL17A
interleukin 17A
treatment
IMP
RGD
PMID:24035250
RGD:9068448
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1R2
interleukin 1 receptor type 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20062062
NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544
G
IL23R
interleukin 23 receptor
no_association
IAGP EXP
DNA:SNPs,haplotype:multiple: DNA:SNP: :rs11209026(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17952073 PMID:20062062 PMID:19522770 PMID:19877036
RGD:8549549 , RGD:8549630
NCBI chr 1:67,138,637...67,265,903
Ensembl chr 1:67,138,907...67,259,979
G
IL6
interleukin 6
IEP
protein:increased expression:serum:
RGD
PMID:26339141
RGD:12792209
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRAK1
interleukin 1 receptor associated kinase 1
susceptibility
IAGP
DNA:SNP:enhancer: (rs3027898) (human)
RGD
PMID:20500689
RGD:7495783
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
G
JAK2
Janus kinase 2
susceptibility
IAGP
DNA:SNPs, haplotype:introns: (rs1536798, rs10119004, rs7857730) (human)
RGD
PMID:20627814
RGD:6483025
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
KDM5A
lysine demethylase 5A
susceptibility
IAGP
DNA:snps:intron:IVST>A, IVS-1467C>T, IVS+828T>C (rs7134353, rs2284336, rs11062357) (human)
RGD
PMID:24069348
RGD:9588532
NCBI chr12:280,057...389,320
Ensembl chr12:280,057...389,320
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility
IAGP
DNA:SNP:cds:677C>T (human)
RGD
PMID:25060515
RGD:42722610
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
PGF
placental growth factor
IEP
RGD
PMID:21873332
RGD:6483576
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
G
PSMB9
proteasome 20S subunit beta 9
IAGP
DNA: snp: rs17587
RGD
PMID:22034108
RGD:6483349
NCBI chr 6:32,854,192...32,859,851
Ensembl chr 6:32,844,136...32,859,851
G
PTGER4
prostaglandin E receptor 4
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21743469 PMID:21743469
RGD:6483530
NCBI chr 5:40,679,915...40,746,800
Ensembl chr 5:40,679,915...40,693,735
G
RUNX3
RUNX family transcription factor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr 1:24,899,511...24,965,138
Ensembl chr 1:24,899,511...24,965,121
G
TAP1
transporter 1, ATP binding cassette subfamily B member
IAGP
DNA:SNPs: :
RGD
PMID:19480848
RGD:6482250
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
TAP2
transporter 2, ATP binding cassette subfamily B member
IAGP
DNA:SNPs: :
RGD
PMID:19480848
RGD:6482250
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
G
TBKBP1
TBK1 binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr17:47,694,063...47,712,063
Ensembl chr17:47,694,161...47,712,052
G
THBD
thrombomodulin
IEP
protein:increased expression:serum
RGD
PMID:21556780
RGD:5684983
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
TLR4
toll like receptor 4
IEP
mRNA:increased expression:blood cell:
RGD
PMID:20952467
RGD:7794744
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR5
toll like receptor 5
IEP
mRNA:increased expression:blood cell:
RGD
PMID:20952467
RGD:7794744
NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,292
G
TNFRSF1B
TNF receptor superfamily member 1B
IDA
RGD
PMID:21317434
RGD:5131280
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
VIP
vasoactive intestinal peptide
IEP
protein:increased expression:plasma
RGD
PMID:20340024
RGD:5685387
NCBI chr 6:152,750,797...152,759,760
Ensembl chr 6:152,750,797...152,759,765
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all